Increased G alpha(q/11) immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder

被引:43
作者
Mathews, R
Li, PP
Young, LT
Kish, SJ
Warsh, JJ
机构
[1] CLARKE INST PSYCHIAT,SECT BIOCHEM PSYCHIAT,TORONTO,ON M5T 1R8,CANADA
[2] UNIV TORONTO,DEPT PSYCHIAT,TORONTO,ON,CANADA
[3] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON,CANADA
[4] UNIV TORONTO,INST MED SCI,TORONTO,ON,CANADA
关键词
G proteins; phospholipase C; bipolar affective disorder; phosphoinositide; signal transduction;
D O I
10.1016/S0006-3223(96)00113-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
As disturbances in guanine nucleotide binding (G) protein-coupled phosphoinositide second messenger systems have been implicated in bipolar disorder, we examined whether the abundance of G alpha(q/11) and phospholipase C (PLC)-beta(1) two key transducing proteins in this signaling pathway, are altered in this disorder, Compared with the controls, immunoreactive levels of G alpha(q/11) were significantly elevated by 62% (p = .047) in occipital cortex of bipolar subjects. A similar increase (52%) in the PLC-beta(1) immunolabeling was also found in the occipital cortex of the bipolar subjects, but only reached marginal statistical significance (p = .07). In contrast, frontal and temporal cortex G(alpha/11) or PLC-beta(1) immunolabeling did not differ between bipolar and control subjects. Cerebral cortical immunoreactive levels of G beta(1) or G beta(2), included as a negative control, were not different between comparison groups. These findings support and extend earlier observations suggesting that disturbances in G protein-coupled second messenger signaling pathways may play an important role in the pathophysiology of bipolar affective disorder. (C) 1997 Society of Biological Psychiatry.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 37 条
[21]  
MANJI HK, 1992, AM J PSYCHIAT, V149, P746
[22]   REDUCED SENSITIVITY OF LYMPHOCYTE BETA-ADRENERGIC RECEPTORS IN PATIENTS WITH ENDOGENOUS-DEPRESSION AND PSYCHOMOTOR AGITATION [J].
MANN, JJ ;
BROWN, RP ;
HALPER, JP ;
SWEENEY, JA ;
KOCSIS, JH ;
STOKES, PE ;
BILEZIKIAN, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :715-720
[23]   AGONIST REGULATION OF CELLULAR G-PROTEIN LEVELS AND DISTRIBUTION - MECHANISMS AND FUNCTIONAL IMPLICATIONS [J].
MILLIGAN, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (11) :413-418
[24]   INTEGRATION OF TRANSMEMBRANE SIGNALING - CROSS-TALK AMONG G-PROTEIN-LINKED RECEPTORS AND OTHER SIGNAL-TRANSDUCTION PATHWAYS [J].
PORT, JD ;
MALBON, CC .
TRENDS IN CARDIOVASCULAR MEDICINE, 1993, 3 (03) :85-92
[25]  
RHEE SG, 1992, J BIOL CHEM, V267, P12393
[26]   NEUROTRANSMITTER-STIMULATED BREAKDOWN OF ENDOGENOUS POLYPHOSPHOINOSITIDES IN POST-MORTEM HUMAN BRAIN [J].
SARRI, E ;
PICATOSTE, F ;
CLARO, E .
NEUROREPORT, 1994, 5 (09) :1059-1062
[27]   HYPERFUNCTIONAL-G PROTEINS IN MONONUCLEAR LEUKOCYTES OF PATIENTS WITH MANIA [J].
SCHREIBER, G ;
AVISSAR, S ;
DANON, A ;
BELMAKER, RH .
BIOLOGICAL PSYCHIATRY, 1991, 29 (03) :273-280
[28]  
SHENKER A, 1991, J BIOL CHEM, V266, P9309
[29]   REGULATION OF PHOSPHOLIPASE-C BY G-PROTEINS [J].
STERNWEIS, PC ;
SMRCKA, AV .
TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (12) :502-506
[30]  
SUH PG, 1988, J BIOL CHEM, V263, P14497